Table 1 Demographic and clinical characteristics.

From: Decreased Gray Matter Volume of Cuneus and Lingual Gyrus in Schizophrenia Patients with Tardive Dyskinesia is Associated with Abnormal Involuntary Movement

Variables

TD (n = 32)

Non-TD (n = 31)

HC (n = 32)

F/T/X 2

P

Sex (M/F)

20/12

19/12

19/13

4, 697

0.096

Age (years)

46.9 ± 10

45.7 ± 7.5

45.6 ± 7.7

0.174

0.841

Education(years)

11.5 ± 2.4

12.4 ± 2.2

11.9 ± 2.2

1.268

0.286

Duration of illness(years)

22.8 ± 10.2

22.6 ± 8.4

—

0.071

0.943

PANSS

   Positive subscore

14.4 ± 5.5

13.8 ± 5.6

—

0.405

0.687

   Negative subscore

22.3 ± 5.8

17.3/6.2

—

3.311

0.002

   General psychopathological subscore

30.9 ± 5.6

31.2 ± 7.2

—

−0.157

0.876

   Total score

67.6 ± 11.7

62.3 ± 13.8

—

1.657

0.103

AIMS

8.6 ± 4.2

—

—

 

—

CPZ equivalents (mg)

508 ± 266

530 ± 224

—

−0.35

0.727

Haloperidol

1

0

   

Amisulpride

1

0

   

Clozapine

16

10

   

Risperidone

4

6

   

Olanzapine

8

8

   

Quetiapine

2

0

   

Perphenazine

0

2

   

Pipotiazine

0

1

   

Sulpiride

0

1

   

Aripiprazole

0

2

   

Lurasidone

0

1

   
  1. p-value indicate significant differences (p < 0.05) in appropriate statistical tests. PANSS: positive and negative syndrome scale; AIMS: Abnormal Involuntary Movement Scale; CPZ: chlorpromazine; TD: patients with schizophrenia and tardive dyskinesia; non-TD: patients with schizophrenia and without tardive dyskinesia; HC healthy subjects.
Back to article page